# Open-Label Study of Diclofenac Capsules to Treat Osteoarthritis Pain

> **NCT01510912** · PHASE3 · COMPLETED · sponsor: **Iroko Pharmaceuticals, LLC** · enrollment: 602 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** Diclofenac

## Key facts

- **NCT ID:** NCT01510912
- **Lead sponsor:** Iroko Pharmaceuticals, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 602 (ACTUAL)
- **Last updated:** 2014-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01510912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01510912, "Open-Label Study of Diclofenac Capsules to Treat Osteoarthritis Pain". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01510912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*